Contrast Media
16
3
3
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
1 terminated out of 16 trials
87.5%
+1.0% vs benchmark
19%
3 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Study on Sex-specific, Individualized Dose Calculation of Contrast Agent in CT Examinations
Optimization of Patient Preparation and Imaging Techniques for Cardiac CT
New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients
Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography
Contrast Media Temperature and Patient Comfort in CT of the Abdomen
Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas
Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body Weight.
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
Improving the Concentration of MR Contrast in the Arteries
Primovist / Eovist in Renally Impaired Patients
Hyperbaric Oxygen Therapy in Distal Radius Fractures: Can it Shorten Recovery Time and Increase Fracture Healing?
Bicarbonate v Saline to Prevent Contrast Nephropathy
CT Versus CEUS Findings of Complex Cystic Renal Lesions
Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients
CT Scan Using IV Contrast Alone for Pediatric Appendicitis